Stacey Wasserman

3.1k total citations · 1 hit paper
17 papers, 2.1k citations indexed

About

Stacey Wasserman is a scholar working on Cognitive Neuroscience, Psychiatry and Mental health and Clinical Psychology. According to data from OpenAlex, Stacey Wasserman has authored 17 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cognitive Neuroscience, 9 papers in Psychiatry and Mental health and 6 papers in Clinical Psychology. Recurrent topics in Stacey Wasserman's work include Autism Spectrum Disorder Research (12 papers), Attention Deficit Hyperactivity Disorder (7 papers) and Obsessive-Compulsive Spectrum Disorders (5 papers). Stacey Wasserman is often cited by papers focused on Autism Spectrum Disorder Research (12 papers), Attention Deficit Hyperactivity Disorder (7 papers) and Obsessive-Compulsive Spectrum Disorders (5 papers). Stacey Wasserman collaborates with scholars based in United States, Canada and United Kingdom. Stacey Wasserman's co-authors include Eric Hollander, William F. Chaplin, Evdokia Anagnostou, Latha Soorya, Ann Phillips, Jennifer A. Bartz, Jennifer Sumner, Sherie Novotny, Rupa Iyengar and Katherine Esposito and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Neuropsychopharmacology.

In The Last Decade

Stacey Wasserman

17 papers receiving 2.0k citations

Hit Papers

Oxytocin Increases Retention of Social Cognition in Autism 2006 2026 2012 2019 2006 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stacey Wasserman United States 12 1.2k 760 700 534 519 17 2.1k
Latha Soorya United States 26 1.8k 1.4× 780 1.0× 833 1.2× 656 1.2× 866 1.7× 59 3.1k
Robin A. Libove United States 19 994 0.8× 375 0.5× 475 0.7× 471 0.9× 381 0.7× 27 1.6k
Charlotte Modahl United States 11 880 0.7× 260 0.3× 668 1.0× 331 0.6× 525 1.0× 12 1.6k
Evelyn Herbrecht Switzerland 7 820 0.7× 312 0.4× 540 0.8× 547 1.0× 316 0.6× 15 1.4k
Sherie Novotny United States 8 706 0.6× 512 0.7× 389 0.6× 361 0.7× 268 0.5× 10 1.2k
Toshio Munesue Japan 25 1.1k 0.9× 269 0.4× 505 0.7× 227 0.4× 245 0.5× 62 1.7k
Éric Lemonnier France 23 1.5k 1.2× 412 0.5× 307 0.4× 274 0.5× 1.1k 2.2× 56 2.5k
Joseph Piven United States 12 1.9k 1.5× 433 0.6× 578 0.8× 721 1.4× 1.1k 2.2× 15 2.9k
Miho Kuroda Japan 14 865 0.7× 231 0.3× 224 0.3× 362 0.7× 203 0.4× 26 1.2k
Concetta DeCaria United States 26 682 0.6× 803 1.1× 445 0.6× 2.1k 3.9× 119 0.2× 46 2.9k

Countries citing papers authored by Stacey Wasserman

Since Specialization
Citations

This map shows the geographic impact of Stacey Wasserman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stacey Wasserman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stacey Wasserman more than expected).

Fields of papers citing papers by Stacey Wasserman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stacey Wasserman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stacey Wasserman. The network helps show where Stacey Wasserman may publish in the future.

Co-authorship network of co-authors of Stacey Wasserman

This figure shows the co-authorship network connecting the top 25 collaborators of Stacey Wasserman. A scholar is included among the top collaborators of Stacey Wasserman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stacey Wasserman. Stacey Wasserman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Anagnostou, Evdokia, Latha Soorya, William F. Chaplin, et al.. (2012). Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial. Molecular Autism. 3(1). 16–16. 271 indexed citations
2.
Girgis, Ragy R., Mark Slifstein, Xiaoyan Xu, et al.. (2011). The 5-HT 2A receptor and serotonin transporter in Asperger's Disorder: A PET study with [ 11 C]MDL 100907 and [ 11 C]DASB. Psychiatry Research Neuroimaging. 194(3). 230–234. 33 indexed citations
3.
Hollander, Eric, Latha Soorya, William F. Chaplin, et al.. (2011). A Double-Blind Placebo-Controlled Trial of Fluoxetine for Repetitive Behaviors and Global Severity in Adult Autism Spectrum Disorders. American Journal of Psychiatry. 169(3). 292–299. 131 indexed citations
4.
Hollander, Eric, William F. Chaplin, Latha Soorya, et al.. (2009). Divalproex Sodium vs Placebo for the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorders. Neuropsychopharmacology. 35(4). 990–998. 136 indexed citations
5.
Hollander, Eric, et al.. (2006). ADouble-Blind Placebo-Controlled Pilot Study of Olanzapine in Childhood/Adolescent Pervasive Developmental Disorder. Journal of Child and Adolescent Psychopharmacology. 16(5). 541–548. 125 indexed citations
6.
Wasserman, Stacey, Rupa Iyengar, William F. Chaplin, et al.. (2006). Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study. International Clinical Psychopharmacology. 21(6). 363–367. 88 indexed citations
7.
Hollander, Eric, Erika N. Swanson, Evdokia Anagnostou, et al.. (2006). Liquid Fluoxetine versus Placebo for Repetitive Behaviors in Childhood Autism. 1(1). 105–113. 2 indexed citations
8.
Hollander, Eric, Jennifer A. Bartz, William F. Chaplin, et al.. (2006). Oxytocin Increases Retention of Social Cognition in Autism. Biological Psychiatry. 61(4). 498–503. 539 indexed citations breakdown →
9.
Anagnostou, Evdokia, Latha Soorya, Erika N. Swanson, et al.. (2006). DIVALPROEX SODIUM VS.PLACEBO IN CHILDHOOD/ADOLESCENT AUTISM. Neuropediatrics. 37(S 1). 1 indexed citations
10.
Anagnostou, Evdokia, Latha Soorya, Erika N. Swanson, et al.. (2006). Divalproex sodium vs. placebo for the treatment of child and adolescent autism. European Neuropsychopharmacology. 16. S74–S75. 1 indexed citations
11.
Hollander, Eric, Latha Soorya, Stacey Wasserman, et al.. (2005). Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder. The International Journal of Neuropsychopharmacology. 9(2). 209–209. 98 indexed citations
12.
Hollander, Eric, Evdokia Anagnostou, William F. Chaplin, et al.. (2005). Striatal Volume on Magnetic Resonance Imaging and Repetitive Behaviors in Autism. Biological Psychiatry. 58(3). 226–232. 285 indexed citations
13.
Novotny, Sherie, Eric Hollander, Ann Phillips, et al.. (2004). Increased repetitive behaviours and prolactin responsivity to oral m-chlorophenylpiperazine in adults with autism spectrum disorders. The International Journal of Neuropsychopharmacology. 7(3). 249–254. 8 indexed citations
14.
Hollander, Eric, Ann Phillips, William F. Chaplin, et al.. (2004). A Placebo Controlled Crossover Trial of Liquid Fluoxetine on Repetitive Behaviors in Childhood and Adolescent Autism. Neuropsychopharmacology. 30(3). 582–589. 265 indexed citations
15.
Hollander, Eric, et al.. (2003). Venlafaxine in Treatment-Resistant Obsessive-Compulsive Disorder. The Journal of Clinical Psychiatry. 64(5). 546–550. 40 indexed citations
16.
Wasserman, Stacey. (2001). States respond to growing abuse of painkiller.. PubMed. 27(9). 33–4. 3 indexed citations
17.
Wasserman, Stacey & Melvin D. Yahr. (1980). Choreic Movements Induced by the Use of Methadone. Archives of Neurology. 37(11). 727–728. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026